Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans

Journal of Applied Physiology

Volumn 97, Issue 2, 2004, Pages 689-696

  Holmes, Anna G ^a   Watt, Matthew J ^a   Febbraio, Mark A ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Cytokines; Fat metabolism; Nicotinic acid; Skeletal muscle

Indexed keywords

ADRENALIN; CARBOHYDRATE; FATTY ACID; GLUCOSE; GLYCOGEN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LACTIC ACID; MESSENGER RNA;

ADIPOSE TISSUE; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; IMMUNE SYSTEM; INSULIN BLOOD LEVEL; LIPID OXIDATION; LIPOLYSIS; MALE; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; EPINEPHRINE; EXERCISE; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GLYCOGEN; HUMANS; INTERLEUKIN-6; LIPOLYSIS; MALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; REST; RNA, MESSENGER;

EID: 3242661646     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00195.2004     Document Type: Article

References (45)

1. Adamopoulos S, Parissis JT, Georgiadis M, Karatzas D, Paraskevaidis J, Kroupis C, Karavolias G, Koniavitou K, and Kremastinos DT. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am Heart J 144: 359-364, 2002.
2. Bergström J, Hultman E, Jorfeldt L, Pernow B, and Wahren J. Effect of nicotinic acid on physical working capacity and on metabolism of muscle glycogen in man. J Appl Physiol 26: 170-176, 1969.
3. Carlson LA, Havel RJ, Ekelund LG, and Holmgren A. Effect of nicotinic acid on the turnover rate and oxidation of the free fatty acids of plasma in man during exercise. Metabolism 12: 837-845, 1963.
4. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
5. De Rijk RH, Boelen A, Tilders FJ, and Berkenbosch F. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19: 155-163, 1994.
6. Fain JN and Bahouth SW. Regulation of lipolysis and leptin biosynthesis in rodent adipose tissue by growth hormone. Metabolism 49: 239-244, 2000.
7. Febbraio MA and Koukoulas I. HSP72 gene expression progressively increases in human skeletal muscle during prolonged, exhaustive exercise. J Appl Physiol 89: 1055-1060, 2000.
8. Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krastrup P, Secher NH, and Pedersen BK. Hepatosplanchnic clearance of interleukin-6 in humans. Am J Physiol Endocrinol Metab 285: E397-E402, 2003.
9. Febbraio MA and Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16: 1335-1347, 2002.
10. Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krastrup P, Ott P, Secher NH, and Pedersen BK. Glucose ingestion attenuates IL-6 release from contracting skeletal muscle in humans. J Physiol 549: 607-612, 2003.
11. 2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 286: E809-E817, 2004.
12. Gollnick PD, Pernow B, Essen B, Jansson E, and Saltin B. Availability of glycogen and plasma NEFA for substrate utilisation in leg muscle of man during exercise. Clin Physiol 1: 27-42, 1981.
13. Hawley JA, Burke LM, Angus DJ, Fallon KE, Martin DT, and Febbraio MA. Effect of altering substrate availability on metabolism and performance during intense exercise. Br J Nutr 84: 829-838, 2000.
14. Helge JW, Stallknecht B, Pedersen BK, Galbo H, Kiens B, and Richter EA. The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol 546: 299-305, 2003.
15. Jensen MD. Cytokine regulation of lipolysis in humans? J Clin Endocrinol Metab 88: 3003-3004, 2003.
16. Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, and Pedersen BK. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun 310: 550-554, 2003.
17. Keller C, Keller P, Marshal S, and Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise-effect of carbohydrate ingestion. J Physiol 550: 927-31, 2003.
18. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, and Neufer PD. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15: 2748-2750, 2001.
19. Kunz-Ebrecht SR, Mohamed-Ali V, Feldman PJ, Kirschbaum C, and Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav Immun 17: 373-383, 2003.
20. Langberg H, Olesen JL, Gemmer C, and Kjær M. Substantial elevation of interleukin-6 concentration in peritendonous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 542: 985-990, 2002.
21. Lyngsø D, Simonsen I, and Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543: 373-378, 2002.
22. Lyngso D, Simonsen L, and Bulow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543: 379-386, 2002.
23. Minghini A, Britt LD, and Hill MA. Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: in vitro versus in vivo studies. Shock 9: 210-215, 1998.
24. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, and Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200, 1997.
25. Nam SY and Marcus C. Growth hormone and adipocyte function in obesity. Horm Res 53: 87-97, 2000.
26. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, and Feingold KR. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136: 2143-2149, 1995.
27. Nybo L, Nielsen B, Pedersen BK, M̂ller K, and Secher NH. Interleukin-6 release from human brain during exercise. J Physiol 542: 991-995, 2002.
28. Orban Z, Remaley AT, Sampson M, Trajanoski Z, and Chrousos GP. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 84: 2126-2133, 1999.
29. Ottosson M, Lonnroth P, Bjorntorp P, and Eden S. Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 85: 799-803, 2000.
30. Pedersen BK, Steensberg A, and Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 536: 329-337, 2001.
31. Péronnet F and Massicotte D. Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16: 23-29, 1991.
32. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, and Klibanski A. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133: 111-122, 2000.
33. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, and Febbraio MA. Carbohydrate attenuates the increase in plasma IL-6, but not in skeletal muscle IL-6 mRNA, during exercise in humans. J Physiol 533: 585-591, 2001.
34. Starkie RL, Rolland J, Angus DJ, Anderson MJ, and Febbraio MA. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-α levels after prolonged running. Am J Physiol Cell Physiol 280: C769-C774, 2001.
35. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, and Pedersen BK. Low glycogen content increases interleukin-6 in contracting human skeletal muscle. J Physiol 537: 633-639, 2001.
36. Steensberg A, Toft AD, Schjerling P, Halkjaer-Kristensen, and Pedersen BK. Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am J Physiol Cell Physiol 281: C1001-C1004, 2001.
37. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, and Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529: 237-242, 2000.
38. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, and Sauerwein HP. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol Endocrinol Metab 268: E813-E819, 1995.
39. Swolin D and Ohlsson C. Growth hormone increases interleukin-6 produced by human osteoblast-like cells. J Clin Endocrinol Metab 81: 4329-4333, 1996.
40. Tseng YH, Kessler MA, and Schuler LA. Regulation of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 expression by growth hormone and prolactin in bovine thymic stromal cells. Mol Cell Endocrinol 128: 117-127, 1997.
41. Ungerstedt JS, Blomback M, and Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 131: 48-52, 2003.
42. Uronen-Hansson H, Allen ML, Lichtarowicz-Krynska E, Aynsley-Green A, Cole TJ, Hoiden-Guthenberg I, Fryklund L, and Klein N. Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood. Growth Horm IGF Res 13: 282-286, 2003.
43. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
44. Vicennati V. Final hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 26: 905-911, 2002.
45. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, and Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79, 2002.